These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 16959616)
21. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Srodon M; Westra WH Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164 [TBL] [Abstract][Full Text] [Related]
22. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma. Klebe S; Swalling A; Jonavicius L; Henderson DW J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863 [TBL] [Abstract][Full Text] [Related]
23. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity. Bejarano PA; Mousavi F Arch Pathol Lab Med; 2003 Feb; 127(2):193-5. PubMed ID: 12562233 [TBL] [Abstract][Full Text] [Related]
25. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY; Kang MJ; Lee DG; Chung MJ Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274 [TBL] [Abstract][Full Text] [Related]
26. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392 [TBL] [Abstract][Full Text] [Related]
27. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700 [TBL] [Abstract][Full Text] [Related]
28. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique. Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549 [TBL] [Abstract][Full Text] [Related]
29. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study]. Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300 [TBL] [Abstract][Full Text] [Related]
30. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. Roh MS; Hong SH J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048 [TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases]. Romeike BF; Feiden W Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas. El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663 [TBL] [Abstract][Full Text] [Related]
33. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens. Shield PW; Papadimos DJ; Walsh MD Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220 [TBL] [Abstract][Full Text] [Related]
34. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions. Zhu W; Michael CW Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661 [TBL] [Abstract][Full Text] [Related]
35. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Kaufmann O; Dietel M Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746 [TBL] [Abstract][Full Text] [Related]
36. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
37. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids. Gomez-Fernandez C; Jorda M; Delgado PI; Ganjei-Azar P Cancer; 2002 Oct; 96(5):289-93. PubMed ID: 12378596 [TBL] [Abstract][Full Text] [Related]
38. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Chang YL; Lee YC; Liao WY; Wu CT Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379 [TBL] [Abstract][Full Text] [Related]
39. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung. Di Loreto C; Puglisi F; Di Lauro V; Damante G; Beltrami CA Cancer Lett; 1998 Feb; 124(1):73-8. PubMed ID: 9500194 [TBL] [Abstract][Full Text] [Related]
40. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Kim JH; Kim YS; Choi YD; Lee JS; Park CS Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]